Byrne Asset Management’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-350
| Closed | -$6K | – | 591 |
|
|
2023
Q3 | $6K | Hold |
350
| – | – | 0.01% | 389 |
|
|
2023
Q2 | $7K | Hold |
350
| – | – | ﹤0.01% | 443 |
|
|
2023
Q1 | $7K | Hold |
350
| – | – | 0.01% | 434 |
|
|
2022
Q4 | $7.84K | Hold |
350
| – | – | 0.01% | 401 |
|
|
2022
Q3 | $7K | Hold |
350
| – | – | 0.01% | 383 |
|
|
2022
Q2 | $8K | Hold |
350
| – | – | 0.01% | 385 |
|
|
2022
Q1 | $10K | Hold |
350
| – | – | 0.01% | 388 |
|
|
2021
Q4 | $12K | Buy |
+350
| New | +$12K | 0.01% | 366 |
|